Detail
Článek
Web zdroj
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The Role of 3D Power Doppler in Screening for Ovarian Cancer

Asim Kurjak, Sonal Panchal, Edin Medjedovic, Zorancho Petanovski

. 2020 ; 8 (2) : 80-92.

Jazyk angličtina Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc21000463

Background: It is clear that in developed countries more women die annually from ovarian cancer than from all other gynecologic malignancies combined. Objective: The aim of this article is to analyze current possibilities and propose adequate measures which can help the development of effective screening methods/assays for the early detection of epithelial ovarian cancer. Results and Discussion: This article updates the status of ovarian cancer screening and addresses most relevant studies published during the last five years. The developments that followed the review are best summarized in reference to the screening tests, target populations and newly published trials. The possible role of 3D ultrasound technology, especially 3D power Doppler imaging, in early and accurate detection of ovarian malignancy is discussed. We described our new ovarian cancer screening trial, which started in January 2001. Improvements in ultrasound technology such as 3D volume acquisition and 3D power Doppler imaging may have clinical utility in a more reliable identification of an abnormal ovarian vascularity and architecture. 3D volume acquisition allows for careful evaluation of the internal surfaces of cyst walls for excrescences otherwise not appreciated by 2D ultrasound. Conclusion: While the addition of 3D power Doppler provides a new tool for measuring the quality of ovarian tumor angiogenesis, improving accurate diagnosis of ovarian malignancies, its clinical value for the early detection of ovarian carcinoma has yet to be determined.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc21000463
003      
CZ-PrNML
005      
20240902215614.0
007      
cr|cn|
008      
210112s2020 xr a fs 000 0|eng||
009      
AR
024    0_
$a 10.5455/ijbh.2020.8.80-92 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a Kurjak, Asim $u Department of Obstetrics and Gynecology, Medical School University of Zagreb, Zagreb, Croatia; School of Medicine, Sarajevo School of Science and Technology, Sarajevo, Bosnia and Herzegovina
245    14
$a The Role of 3D Power Doppler in Screening for Ovarian Cancer / $c Asim Kurjak, Sonal Panchal, Edin Medjedovic, Zorancho Petanovski
504    __
$a Literatura
520    9_
$a Background: It is clear that in developed countries more women die annually from ovarian cancer than from all other gynecologic malignancies combined. Objective: The aim of this article is to analyze current possibilities and propose adequate measures which can help the development of effective screening methods/assays for the early detection of epithelial ovarian cancer. Results and Discussion: This article updates the status of ovarian cancer screening and addresses most relevant studies published during the last five years. The developments that followed the review are best summarized in reference to the screening tests, target populations and newly published trials. The possible role of 3D ultrasound technology, especially 3D power Doppler imaging, in early and accurate detection of ovarian malignancy is discussed. We described our new ovarian cancer screening trial, which started in January 2001. Improvements in ultrasound technology such as 3D volume acquisition and 3D power Doppler imaging may have clinical utility in a more reliable identification of an abnormal ovarian vascularity and architecture. 3D volume acquisition allows for careful evaluation of the internal surfaces of cyst walls for excrescences otherwise not appreciated by 2D ultrasound. Conclusion: While the addition of 3D power Doppler provides a new tool for measuring the quality of ovarian tumor angiogenesis, improving accurate diagnosis of ovarian malignancies, its clinical value for the early detection of ovarian carcinoma has yet to be determined.
650    17
$a nádory vaječníků $x diagnostické zobrazování $7 D010051 $2 czmesh
650    _7
$a diagnostické techniky porodnicko-gynekologické $7 D003944 $2 czmesh
650    _7
$a ultrasonografie dopplerovská $7 D018608 $2 czmesh
650    _7
$a zobrazování trojrozměrné $7 D021621 $2 czmesh
650    _7
$a multimodální zobrazování $7 D064847 $2 czmesh
650    _7
$a časná detekce nádoru $7 D055088 $2 czmesh
650    _7
$a staging nádorů $7 D009367 $2 czmesh
650    _7
$a míra přežití $7 D015996 $2 czmesh
650    _7
$a nádorové biomarkery $7 D014408 $2 czmesh
650    _7
$a antigen CA-125 $x analýza $7 D018394 $2 czmesh
650    _7
$a lysofosfolipidy $x analýza $7 D008246 $2 czmesh
650    _7
$a lidé $7 D006801 $2 czmesh
650    _7
$a ženské pohlaví $7 D005260 $2 czmesh
650    _7
$a randomizované kontrolované studie jako téma $7 D016032 $2 czmesh
700    1_
$a Panchal, Sonal $u Dr Nagori's Institute for Infertility and IVF, Jodhpur, Ahmedabad, Gujarat, India
700    1_
$a Medjedovic, Edin $u School of Medicine, Sarajevo School of Science and Technology, Sarajevo, Bosnia and Herzegovina; Clinic of Gynecology and Obstetrics, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina
700    1_
$a Petanovski, Zorancho $u In Vitro Fertilization Centre, First Private General Hospital, ReMedika, Skopje, North Macedonia; Medical Faculty, University GoceDelchev, Shtip, North Macedonia
773    0_
$t International journal on biomedicine and healthcare $x 1805-8698 $g Roč. 8, č. 2 (2020), s. 80-92 $w MED00188409
910    __
$a ABA008 $b online $y p $z 0
990    __
$a 20210112113001 $b ABA008
991    __
$a 20240902215611 $b ABA008
999    __
$a ok $b bmc $g 1607062 $s 1120736
BAS    __
$a 3 $a 4
BMC    __
$a 2020 $b 8 $c 2 $d 80-92 $i 1805-8698 $m International journal on biomedicine and healthcare $x MED00188409
LZP    __
$c NLK194 $d 20240902 $a NLK 2021-04/kv

Najít záznam

Citační ukazatele

Možnosti archivace